Canadian Neurological Sciences Federation

Renew Membership

Featured

Dr Bijoy Menon presents breakthrough stroke treatment research at CNSF 2022 Congress

Large Canadian randomized trial shows that Tenecteplase is the preferred thrombolytic drug for stroke

UCalgary researchers with the Calgary Stroke Program make another breakthrough in the treatment of stroke Study shows a heart attack drug can become the standard treatment for acute ischemic stroke. Learn more..

Posted Wednesday, June 29, 2022

2022 Diamond Sponsor
2022 Platinum Sponsor
2022 Gold Sponsors
2022 Gold Sponsors
2022 Gold Sponsors
2022 Gold Sponsors
2022 Silver Sponsor
2022 Silver Sponsors

Contact Us

© 2020 The Canadian Neurological Sciences Federation. All rights reserved.